Safety Assessment for Ophthalmic Products
Cancer Treatments, Clinical Trials, and the Motivation to Innovate
Getting to the Heart of Science with Michelle Newby
At the heart of science are stories—stories of courage, challenges, successes, lessons, and people. These stories motivate us in the pursuit of knowledge and breathe life into the work we do as researchers. They remind us of the immense benefits of drug development.
Design and Validation of a Bioanalytical Method to Support a Clinical Pharmacokinetic Study Involving the Use of Multiple Lots of the Biological Therapeutic Drug
Clinical Trials Arena: CRO Altasciences Works With Alzamend for Phase IIa Trial in Alzheimer's
Contract Pharma: Regulatory Affairs—Accelerating Drug Development Timelines
Top 5 Ways Integrated Drug Development Solutions Save You Time and Money
Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion, without, for the most part, shorter development time